Related references
Note: Only part of the references are listed.The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom
Vidya Navaratnam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
ANTI-FIBROTIC THERAPY MODULATES MORTALITY RISK ASSOCIATED WITH CIRCULATING PLASMA BIOMARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Justin Oldham et al.
CHEST (2019)
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Louise A. Organ et al.
RESPIRATORY RESEARCH (2019)
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease
Fasihul Khan et al.
BMJ OPEN RESPIRATORY RESEARCH (2019)
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis
Ivan O. Rosas et al.
CHEST (2018)
Biomarkers in idiopathic pulmonary fibrosis
F. Drakopanagiotakis et al.
MATRIX BIOLOGY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials
Margaret Neighbors et al.
LANCET RESPIRATORY MEDICINE (2018)
Idiopathic Pulmonary Fibrosis Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers
Ganesh Raghu et al.
CHEST (2018)
Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review
Hirofumi Chiba et al.
RESPIRATORY INVESTIGATION (2018)
Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis
Argyris Tzouvelekis et al.
RESPIROLOGY (2017)
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Julien Guiot et al.
LUNG (2017)
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2017)
Idiopathic pulmonary fibrosis
Fernando J. Martinez et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Postnatal Changes in Humerus Cortical Bone Thickness Reflect the Development of Metabolic Bone Disease in Preterm Infants
Shuko Tokuriki et al.
DISEASE MARKERS (2016)
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Lesley A. Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
Alfonso Iorio et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
Alfonso Iorio et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
R. Gisli Jenkins et al.
LANCET RESPIRATORY MEDICINE (2015)
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis
Akihiko Sokai et al.
RESPIRATORY RESEARCH (2015)
Molecular biomarkers in idiopathic pulmonary fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study
Vidya Navaratnam et al.
THORAX (2014)
Assessing Bias in Studies of Prognostic Factors
Jill A. Hayden et al.
ANNALS OF INTERNAL MEDICINE (2013)
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
Thomas J. Richards et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Individual participant data meta-analysis of prognostic factor studies: state of the art?
Ghada Abo-Zaid et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice
Gavin B. Stewart et al.
PLOS ONE (2012)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
The rising incidence of idiopathic pulmonary fibrosis in the UK
V. Navaratnam et al.
THORAX (2011)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
The pathogenesis of idiopathic pulmonary fibrosis
William R. Coward et al.
Therapeutic Advances in Respiratory Disease (2010)
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis
Takanori Akagi et al.
RESPIRATORY MEDICINE (2009)
Incidence and prevalence of idiopathic pulmonary fibrosis
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
HR Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Share Paper
